Mereo BioPharma Group annual operating margin
2023
2025
Mereo BioPharma Group Operating Margin Growth & History (MREO)
Mereo BioPharma Group's operating margin was −8,021.40% for fiscal 2025.
View full Mereo BioPharma Group company overviewMereo BioPharma Group annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −8,021.40% | — |
| 2023 | 2023-12-31 | −284.16% | — |
Mereo BioPharma Group quarterly operating margin
Q2.23
Q4.23
Q2.25
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2025 | 2025-06-30 | −2,099.80% | — |
| Q4 2023 | 2023-12-31 | −712.80% | — |
| Q2 2023 | 2023-06-30 | −9.01% | — |
Mereo BioPharma Group operating margin trends
Between the periods ended 2023-12-31 and 2025-12-31, Mereo BioPharma Group's operating margin decreased from −284.16% to −8,021.40%, a change of −7737.24 percentage points. The latest reported quarter, Q2 2025, shows −2,099.80%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Mereo BioPharma Group source filings ↗